Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anovulation × Letrozole × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 136 Endometrial Neoplasms 13 Ovarian Neoplasms 10 Recurrence 4 Neoplasms 4 Neoplasm Metastasis 4 Fallopian Tube Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 4 Breast Cancer Metastatic 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Leiomyosarcoma 2 Carcinoma, Lobular 2 Breast Diseases 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Polycystic Ovary Syndrome 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Pain 1 Osteoporosis 1 Neoplastic Cells, Circulating 1 Neoadjuvant Operable Breast Cancer 1 Multiple Endocrine Neoplasia Type 1 1 Medullary cystic kidney disease 1 1 Lymphangioleiomyomatosis 1 Low-Grade Serous Ovarian Cancer 1 Locoregional Recurrence 1

Interventions

salicylsalicylic acid 1 maltodextrin 1 Sodium Salicylate 1 Metformin 1 Letrozole 1 Inulin 1 Inositol 1 Flutamide 1 Clomiphene 1 Chorionic Gonadotropin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02551367 2015-09-16

LVCCFOROI

Ain Shams Maternity Hospital

Phase 2 Unknown

Anovulation, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡